Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Net Equity Issued and Repurchased (2010 - 2025)

Analysis

Cerenome (CNSY) Net Equity Issued and Repurchased (2010 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn -
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn -
5 Revolution Medicines 44.41 Bn 44.41 Bn - 141.90 Mn
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn -
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn -
10 Cerenome 20.42 Mn 11.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.00 Mn
Sep 30, 2025 16.82 Mn
Dec 31, 2023 1.00 Mn
Sep 30, 2023 -2.26 Mn
Jun 30, 2023 1.36 Mn
Mar 31, 2023 895,000.00
Dec 31, 2022 3.20 Mn
Sep 30, 2022 3.20 Mn
Jun 30, 2022 31,000.00
Mar 31, 2022 7.69 Mn
Dec 31, 2021 -6.17 Mn
Sep 30, 2021 6.37 Mn
Jun 30, 2021 5.11 Mn
Mar 31, 2021 7.18 Mn
Dec 31, 2020 4.01 Mn
Sep 30, 2019 13.98 Mn
Jun 30, 2019 65,000.00
Mar 31, 2019 3.80 Mn
Dec 31, 2018 1.70 Mn
Sep 30, 2018 6.45 Mn